Mitochondria-associated ER membranes and Alzheimer disease

• Published in: Current opinion in genetics & development Vol. 38; pp. 90 - 96
• Main Authors: Area-Gomez, Estela, Schon, Eric A
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01-06-2016
• Subjects: Alzheimer Disease - genetics; Alzheimer Disease - pathology; Amyloid beta-Peptides - genetics; Amyloid beta-Peptides - metabolism; Amyloid Precursor Protein Secretases - genetics; Brain - metabolism; Brain - pathology; Cell Membrane - genetics; Endoplasmic Reticulum - genetics; Endoplasmic Reticulum - metabolism; Humans; Medical Education; Mitochondria - genetics; Mitochondria - metabolism
• ISSN: 0959-437X; 1879-0380
• DOI: 10.1016/j.gde.2016.04.006

The series of events underlying the pathogenesis of Alzheimer disease (AD) in unknown. The most widely accepted hypothesis is called the amyloid cascade, based on the observation that the brains of AD patients contain high levels of extracellular plaques, composed mainly of β-amyloid (Aβ), and intracellular tangles, composed of hyperphosphorylated forms of the microtubule-associated protein tau. However, AD is also characterized by other features, including aberrant cholesterol, phospholipid, and calcium metabolism, and mitochondrial dysfunction, all ostensibly unrelated to plaque and tangle formation. Notably, these ‘other’ aspects of AD pathology are functions related to mitochondria-associated ER membranes (MAM), a subdomain of the endoplasmic reticulum (ER) that is apposed to, and communicates with, mitochondria. Given the potential relationship between MAM and AD, we explored the possibility that perturbed MAM function might play a role in AD pathogenesis. We found that γ-secretase activity, which processes the amyloid precursor protein to generate Aβ, is located predominantly in the MAM, and that ER–mitochondrial apposition and MAM function are increased significantly in cells from AD patients. These observations may help explain not only the aberrant Aβ production, but also many of the ‘other’ biochemical and morphological features of the disease. Based on these, and other, data we propose that AD is fundamentally a disorder of ER–mitochondrial hyperconnectivity.